MEDICREA: Third-Quarter Sales Up +22%
LYON, France & NEW YORK--(BUSINESS WIRE)--The MEDICREA group (Alternext Paris: FR0004178572 - ALMED, PEA-PME eligible), which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, announces its sales for the 3rd quarter ending September 30, 2015.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.